A leading blood pressure medication is being voluntarily recalled due to a packaging error that could lead to patients receiving an incorrect dose of the drug. The recall affects bottles of Amlodipine besylate tablets from the brand ‘Amlodipine 5mg’ manufactured in India and distributed by the company, Dr Reddy’s Laboratories. The company has confirmed that the medication label was printed with a different dosage than what was actually contained within the bottles. This discrepancy could potentially cause harmful side effects if patients do not take the correct dose of the drug. The FDA is urging anyone who purchased this particular batch to immediately stop using it and consult their healthcare provider for further instructions. Dr Reddy’s Laboratories has assured its customers that they are taking steps to rectify the issue, including a comprehensive investigation into the cause of the error and implementing measures to prevent such incidents in the future.